Pattern Bioscience · 7 hours ago
RevOps Data Analyst
Pattern is a rapidly growing company that accelerates brands on global ecommerce marketplaces through advanced technology and AI. The RevOps Data Analyst Intern will analyze sales and revenue operations data, collaborate with various stakeholders, and provide strategic recommendations to enhance sales activities.
BiotechnologyHealth CareMedical
Responsibilities
Conduct data analyses into our sales and marketing data to unearth insights and inform improved go-to-market strategies
Work cross functionally to elevate data insights and processes in partnership with other Pattern teams including Sales, Data Science, Marketing, and Finance
Build out scalable reporting tools to answer track performance and enable team to act quickly and confidently
You will develop and present recommendations to Executive leadership at the conclusion of your internship
Qualification
Required
Must be a graduate student or a senior in college enrolled in a degree in Business, Finance, Economics, Accounting, or related field
You have a current understanding of sales strategies, best practices, and associated resources
GPA is 3.7 or higher
Outstanding analytical and data management skills including experience with SQL
Teachable and fast learner
Self-motivated and proactive
High ethical standards
Preferred
Experience in .com or marketplace commercial efforts (D2C, Amazon, Walmart.com, etc.) is a plus
Experience with Python, Tableau, Snowflake, and/or R is beneficial
Company
Pattern Bioscience
Pattern Bioscience is a biotech diagnostics company that helps to combat the problem of antibiotic resistance.
H1B Sponsorship
Pattern Bioscience has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (2)
2023 (1)
Funding
Current Stage
Late StageTotal Funding
$95.89MKey Investors
Illumina VenturesOmnimed CapitalCARB-X
2025-08-18Series D· $44.22M
2023-04-27Series C· $28.7M
2020-07-14Series B· $6M
Recent News
2025-08-19
2025-05-04
2025-02-08
Company data provided by crunchbase